Dr Laura Broughton

Laura Broughton is a Research Development Assistant at the University of Hull and Hull University Teaching Hospitals NHS Trust. Laura graduated from the University of Hull in 2012 with a BSc Hons Biomedical Science and from Hull York Medical School in 2017 with a PhD Medical Science. Laura’s laboratory research has investigated the thrombotic potential of leukaemia, pancreatic and ovarian cancers. In 2018, Laura began working with Professor Maraveyas’ team at Castle Hill Hospital and is a member of the VTE multi-disciplinary team, providing support to the award winning Nurse Led Pathway for Incidental Pulmonary Embolism (IPE) in Cancer Patients in Hull. Laura has developed a number of local and national clinical trials in oncology.

Professor Anthony Maraveyas

Anthony is a Professor and Consultant in Medical Oncology at the University of Hull and Hull University Teaching Hospitals NHS Trust. Anthony graduated from Athens Medical School in 1983 and completed internal medicine training in 1990. In 1995 he was awarded PhD from the University of London. Appointed at the University of Hull in 1999 as part of the founding team of Hull York Medical School, he is now a professor of Cancer Medicine and the Director for the Clinical Sciences Centre. Anthony is the Co-Chair of the International Society on Thrombosis and Haemostasis (ISTH) SSG group in Cancer and Thrombosis. Anthony is a member of guideline producing committees for CAT for the organisations; ESMO (European Society for Medical Oncology), ITAC (International Initiative on Thrombosis and Cancer), BSH (British Society of Haematology), EHA (European Haematology Association) and ISTH. Amongst his clinical research activity he has been national chief investigator for a number of studies in CAT and has published widely in this field with particular focus on the thromboprophylaxis of the ambulant cancer patient and the management of IPE. He is Chair of the VTE multi-disciplinary team and the award winning Nurse Led Pathway for IPE in Cancer Patients in Hull. Anthony treats pancreaticobiliary, kidney cancer and melanoma.

Sarah Scargill

Sarah is a senior principal clinical pharmacist and lead for cancer services at Hull University Teaching Hospitals NHS Trust and an embedded pharmacist working for NHS England (NHSe) Specialist Commissioning. Sarah graduated from the University of Brighton with a BSc Hons Pharmacy in 1996, from University of Bradford with an MSc Clinical Pharmacy Diploma (Hospital) in 2000 and from University of Hull with an MSc Advanced Clinical Practice in 2021. Sarah has been an Independent Non-Medical Prescriber since 2012. Sarah is responsible for overseeing the clinical pharmacy service provided to oncology and haematology from a dedicated cancer centre. In addition she provides a liaison role between NHSe specialist commissioning and provider trusts across the cancer network. Sarah is the trust lead pharmacist for the JACIE transplant accreditation programme, and for the national peer review program overseen by the Department of Health and Social Care. Sarah contributes to the national commissioning cancer pharmacists group and provides education and support to pharmacists and commissioners within the Humber and North Yorkshire Cancer Alliance. Sarah teaches on the MSc Clinical Pharmacy programme at the University of Bradford and is a practice supervisor for the Non-Medical Prescribing programme at the University of York.

Kieron Power

Kieron is the principal pharmacist for thrombosis and anticoagulation in Swansea Bay University Health Board in South Wales. Kieron graduated from Portsmouth University in 2009 and started specialising in anticoagulation in 2015. His current role is as clinical lead for the health board acute VTE service, running a once weekly complex thrombosis and anticoagulation clinic for the haematology department, and as health board VTE lead in the context of governance and performance. The acute VTE service has been recognised for its work in CAT management by winning awards in the Welsh Pharmacy Awards, European Association of Hospital Pharmacists awards, and being recognised at the Anticoagulant Achievement Awards. Kieron is the secretary for the health board Thrombosis and Anticoagulation committee and a committee member of the UK Clinical Pharmacy Association Haemostasis and Thrombosis Group. Kieron has undertaken additional work in the field of CAT by being an author on a collaborative CAT management guideline published in 2022 and supporting healthcare professional training and development in the field by consulting on the development of websites and educational videos.

Nathan Hutchinson-Jones

Nathan is the Lead Pharmacist for Thrombosis and Anticoagulation at the Royal United Hospital (RUH), Bath. Nathan studied at Cardiff University before qualifying as a pharmacist in 2013. Nathan is an independent prescriber and leads a team of specialist nurses and pharmacists. Nathan’s role is varied; however he has a particular interest in the management of CAT. Nathan set up a pharmacist led CAT clinic in 2017, which won an award for the “Best work in cancer associated thrombosis” at the Anticoagulation Achievement Awards in London in 2018. Nathan successfully completed his MSc in Clinical Pharmacy in 2022 after carrying out a research project exploring patient and health care professional needs of a dedicated CAT clinic. Nathan is a member of the UK Clinical Pharmacy Association Haemostasis and Thrombosis Group and has been involved in numerous talks and projects both on a local, regional and national level. He is actively involved in the education and training of healthcare professionals locally and pharmacy undergraduate/postgraduate students at the University of Bath.